Theriva Biologics Inc
SYN
Market Cap$16.16M
Close$
$1.57
54.2% upside
Current Fair Value
54.2% upsideUndervalued by 54.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.16 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 1.04 |
| Outstanding Shares | 15,844,061 |
| Avg 30 Day Volume | 51,801 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Synthetic Biologics Inc
CEO: Steven Shallcross